Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2025-12-25 @ 3:56 AM
NCT ID:
NCT02214602
Eligibility Criteria:
Inclusion Criteria:
* Ability to give informed consent.
* Patients with primary or recurrent papillary Non muscle invasive bladder cancer (NMIBC).
* Complete transurethral resection of bladder tumor(TURBT).
* Normal cardiac, hematological, and renal functions.
* Patients with intermediate and high risk NMIBC confirmed by histopathology.
Exclusion Criteria:
* Inability to give informed consent.
* Patients with history of previous radiotherapy or systemic chemotherapy.
* Patients suffering from immuno-deficiency or other malignancies.
* Patients with history of hypersensitivity reaction to epirubicin.
* Examination under anesthesia (EUA) reveals palpable bladder mass.
* Patients with primary, single, less than 1cm papillary bladder tumor (high likelihood of being low risk).
* Suspicion of perforation of the bladder during TURBT.
* Patients who develop hematuria in the recovery room necessitating continuous bladder wash or endoscopic haemostasis.
* Patients with proven low risk NMIBC on histopathology.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02214602
Study Brief:
Protocol Section:
NCT02214602